Welcome to Elekta’s Capital Markets Day in Stockholm on June 11, 2015
Speakers at the event will be Tomas Puusepp, Elekta’s President and CEO, and other members of Elekta’s management team.
To attend, please register by e-mail to Frida.Johansson@elekta.com no later than May 29, 2015.
It will also be possible to follow the Capital Markets Day over the phone and as a live webcast. Please note that we only will be able to take questions from the participants at place at the Capital Markets Day.
Live webcast: http://elekta-live.creo.tv/cmd-2015
To take part over the phone, please dial in about 5-10 minutes in advance and use the access code: 424439#.
- Sweden: +46 8 505 564 53
- UK: +44 20 3009 2455
- US: +1 855 228 3719
We look forward to your participation on June 11, 2015.
Director Investor Relations
Director Financial Communication
# # #
For further information, please contact:
Frida Johansson, Investor Relations Coordinator, Elekta AB (publ)
Tel: +46 70 866 76 74, e-mail: Frida.Johansson@elekta.com
Time zone: CET: Central European Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.